• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Astronics Corporation Reports 2023 Second Quarter Financial Results

    8/3/23 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials
    Get the next $ATRO alert in real time by email
    • Sales for the quarter were $174.5 million, up 35% over prior year, and 11% sequentially
    • Bookings totaled $207.1 million
    • Record backlog of $611.1 million
    • Aerospace segment sales increased 45% to $158.4 million; bookings were $188.8 million
    • Income from operations was $2.4 million in the quarter; net loss was $12.0 million after $8.1 million tax expense
    • Adjusted EBITDA1 grew to $15.8 million, or 9.1% of sales

    Astronics Corporation (NASDAQ:ATRO) ("Astronics" or the "Company"), a leading supplier of advanced technologies and products to the global aerospace, defense and other mission critical industries, today reported financial results for the three and six months ended July 1, 2023.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230803576443/en/

    ATRO Segment Sales and Bookings Chart (Graphic: Business Wire)

    ATRO Segment Sales and Bookings Chart (Graphic: Business Wire)

    Peter J. Gundermann, Chairman, President and Chief Executive Officer, commented, "Our second quarter results show the momentum in our business as the commercial aerospace industry advances its recovery. Demand for our products is high and our supply chain continues to improve. Revenue of $175 million was a significant step up sequentially and year-over-year, and bookings of $207 million were at pre-pandemic levels. We believe we are set for a strong second half of 2023 and, if current trends continue, an even stronger 2024."

    _____________________________ 

    1 Adjusted EBITDA is a Non-GAAP Performance Measure. Please see the attached table for a reconciliation of adjusted EBITDA to GAAP net loss.

    Second Quarter Results

     

    Three Months Ended

     

    Six Months Ended

    ($ in thousands)

    July 1, 2023

     

    July 2, 2022

    % Change

     

    July 1, 2023

     

    July 2, 2022

    % Change

     

     

     

     

     

     

     

     

     

     

    Sales

    $

    174,454

     

     

    $

    129,127

     

    35.1

    %

     

    $

    330,992

     

     

    $

    245,303

     

    34.9

    %

    Income (Loss) from Operations

    $

    2,396

     

     

    $

    (8,396

    )

    128.5

    %

     

    $

    26

     

     

    $

    (12,563

    )

    100.2

    %

    Operating Margin %

     

    1.4

    %

     

     

    (6.5

    )%

     

     

     

    —

    %

     

     

    (5.1

    )%

     

    Net Gain on Sale of Business

    $

    —

     

     

    $

    —

     

     

     

    $

    (3,427

    )

     

    $

    (11,284

    )

     

    Net Loss

    $

    (11,999

    )

     

    $

    (11,010

    )

    (9.0

    )%

     

    $

    (16,414

    )

     

    $

    (14,111

    )

    (16.3

    )%

    Net Loss %

     

    (6.9

    )%

     

     

    (8.5

    )%

     

     

     

    (5.0

    )%

     

     

    (5.8

    )%

     

     

     

     

     

     

     

     

     

     

     

    *Adjusted EBITDA

    $

    15,844

     

     

    $

    2,081

     

    661.4

    %

     

    $

    21,922

     

     

    $

    3,030

     

    623.5

    %

    *Adjusted EBITDA Margin %

     

    9.1

    %

     

     

    1.6

    %

     

     

     

    6.6

    %

     

     

    1.2

    %

     

     

    *Adjusted EBITDA is a Non-GAAP Performance Measure. Please see the attached table for a reconciliation of adjusted EBITDA to GAAP net loss.

    Second Quarter 2023 Results (compared with the prior-year period, unless noted otherwise)

    Consolidated sales were up $45.3 million, or 35.1%, from the second quarter of 2022, and up 11.4% sequentially. Aerospace sales increased $49.1 million over the comparator quarter, or 44.9%, driven primarily by higher sales to the commercial transport market. Test Systems sales decreased $3.8 million on lower defense revenue.

    Consolidated operating income was $2.4 million, an improvement over an operating loss of $8.4 million in the prior-year period. The current period operating income improvement was driven by the contribution margin from the increased sales. The current period was impacted by litigation-related legal expenses of $4.9 million partially offset by a reduction in legal reserves of $1.3 million.

    Interest expense was $5.9 million in the current period, compared with $1.7 million in the prior-year period, primarily driven by higher interest rates on the Company's new credit facilities. Interest expense includes approximately $0.7 million of non-cash amortization of capitalized financing-related fees.

    Income tax expense was $8.1 million in the current period, primarily due to a valuation allowance applied against the deferred tax asset associated with research and development costs that are required to be capitalized for tax purposes.

    Consolidated net loss was $12.0 million, or $0.37 per diluted share, compared with net loss of $11.0 million, or $0.34 per diluted share, in the prior year.

    Consolidated adjusted EBITDA was $15.8 million, or 9.1% of consolidated sales, compared with an adjusted EBITDA of $2.1 million, or 1.6% of consolidated sales, in the prior-year period.

    Bookings were $207.1 million in the quarter resulting in a book-to-bill ratio of 1.19:1. The quarter closed with a record backlog of $611.1 million. Approximately $502.0 million of backlog is expected to ship over the next twelve months.

    Aerospace Segment Review (refer to sales by market and segment data in accompanying tables)

    Aerospace Second Quarter 2023 Results (compared with the prior-year period, unless noted otherwise)

    Aerospace segment sales increased $49.1 million, or 44.9%, to $158.4 million, and up 16.8% sequentially. The increase was driven by a 61.9% increase, or $42.8 million, in commercial transport sales. Sales to this market were $112.1 million, or 64.3% of consolidated sales in the quarter, compared with $69.2 million, or 53.6% of consolidated sales in the second quarter of 2022. Improving global airline travel driving higher fleet utilization and increased production rates resulted in increased demand.

    General Aviation sales increased $6.9 million, or 38.0%, to $25.0 million.

    Aerospace segment operating profit improved to $13.7 million, or 8.7% of sales, compared with operating loss of $3.3 million in the same period last year. The improved operating profit was driven by higher volume primarily in the commercial transport market.

    Aerospace bookings were $188.8 million for a book-to-bill ratio of 1.19:1. Backlog for the Aerospace segment was a record $522.6 million at quarter end.

    Mr. Gundermann commented, "The recovery in our Aerospace segment over the last four quarters has been dramatic, with revenue increasing from $112 million per quarter to $158 million. Bookings during that period have totaled $656 million with a book-to-bill of 1.21:1, indicating strong demand for our products and opportunity for further growth. The increase in global passenger travel is driving the recovery, resulting in higher production rates and retrofit activity across all portions of the industry."

    Test Systems Segment Review (refer to sales by market and segment data in accompanying tables)

    Test Systems Second Quarter 2023 Results (compared with the prior-year period, unless noted otherwise)

    Test Systems segment sales were $16.1 million, down $3.8 million primarily as a result of lower defense revenue.

    Test Systems segment operating loss was $6.1 million compared with nearly break-even in the second quarter of 2022. Test Systems operating loss for the current period was negatively affected by mix, under absorption of fixed costs due to volume and $2.2 million in increased litigation-related legal expenses.

    Shortly after the first quarter ended, the Test Systems segment implemented restructuring initiatives to align the workforce and management structure with near-term revenue expectations and operational needs. These initiatives are expected to provide savings of $4 million to $5 million annually, beginning with the third quarter.

    Bookings for the Test Systems segment in the quarter were $18.3 million and included the initial $9.6 million production order for the Handheld Radio Test Sets ("HHRTS") Program for the U.S. Marine Corps. Book-to-bill ratio was 1.14:1 for the quarter. Backlog was $88.5 million at the end of the second quarter of 2023 compared with backlog of $83.6 million at the end of the second quarter of 2022.

    In April 2023, Astronics announced that the Test business had been awarded a contract award to produce portable radio test equipment for the U.S. Marine Corps' HHRTS Program. This program is expected to generate revenue of approximately $40 million over a five-year period.

    Mr. Gundermann commented, "Our Test business had a difficult quarter, with lower-than-expected revenue and high legal costs. We expect significant improvement in the coming quarters as our radio test programs advance, setting up 2024 as a much better year."

    Liquidity and Financing

    Cash on hand at the end of the quarter was $4.3 million. Capital expenditures in the quarter were $2.2 million. Net debt was $178.7 million.

    Cash used for operations was $2.0 million in second quarter of 2023, improving from cash used of $19.2 million in the prior quarter. Astronics expects to be cash flow positive for the remainder of 2023. During the quarter, higher inventory and accounts receivable were partially offset by increased accounts payable and accrued expenses.

    David Burney, the Company's CFO, said, "Our liquidity during the second quarter was tighter than expected as inventory levels continued to increase. We are challenged by elevated inventory levels as we forecast strong sales growth but struggle with the inefficiencies in the supply chain. We expect inventory levels to begin to decline and liquidity to improve as we move through the second half of the year."

    2023 Outlook

    Revenue guidance for 2023 is unchanged at $640 million to $680 million with expectations of achieving the higher end of the range. Planned capital expenditures for 2023 are expected to be in the range of $7 million to $12 million.

    Peter Gundermann commented, "We are pleased with the progress we made in the first half of 2023 and are confident about the second half as well. Demand remains strong, and our supply chain, though imperfect, continues to improve. We feel we have line of sight to the high end of our range based on existing backlog and the established momentum of our revenue ramp. Sales in the first half of the year were $331 million and we began the second half of 2023 with $330 million of scheduled backlog. With that, we expect our typical additional drop-in and pull-in orders could deliver revenue at the high end of our guidance. There's modest risk with the supply chain and timing of major Test segment contract awards. We expect margins to continue to improve with expected increases in volume, lower cost inputs, pricing improvements, and the effects of restructuring activities accomplished in the second quarter. We also expect our year end to be busy with shipments and continued demand strength, setting up for another strong year of improvement in 2024."

    Second Quarter 2023 Webcast and Conference Call

    The Company will host a teleconference today at 4:45 p.m. ET. During the teleconference, management will review the financial and operating results for the period and discuss Astronics' corporate strategy and outlook. A question-and-answer session will follow.

    The Astronics conference call can be accessed by calling (412) 317-5180. The listen-only audio webcast can be monitored at investors.astronics.com. To listen to the archived call, dial (412) 317-6671 and enter replay pin number 10180028. The telephonic replay will be available from 8:00 p.m. on the day of the call through Thursday, August 17, 2023. A transcript of the call will also be posted to the Company's Web site once available.

    About Astronics Corporation

    Astronics Corporation (NASDAQ:ATRO) serves the world's aerospace, defense, and other mission critical industries with proven, innovative technology solutions. Astronics works side-by-side with customers, integrating its array of power, connectivity, lighting, structures, interiors, and test technologies to solve complex challenges. For over 50 years, Astronics has delivered creative, customer-focused solutions with exceptional responsiveness. Today, global airframe manufacturers, airlines, military branches, completion centers, and Fortune 500 companies rely on the collaborative spirit and innovation of Astronics. The Company's strategy is to increase its value by developing technologies and capabilities that provide innovative solutions to its targeted markets.

    Safe Harbor Statement

    This news release contains forward-looking statements as defined by the Securities Exchange Act of 1934. One can identify these forward-looking statements by the use of the words "expect," "anticipate," "plan," "may," "will," "estimate" or other similar expressions and include all statements with regard to achieving any revenue or profitability expectations, the rate of recovery of the commercial aerospace widebody/long haul markets, the improvement in the supply chain and reduction of spot buys, the timing of pricing and impact of inflation on margins, the effectiveness on profitability of cost reduction efforts, the timing of receipt of task orders or future orders, and the expectations of demand by customers and markets. Because such statements apply to future events, they are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated by the statements. Important factors that could cause actual results to differ materially from what may be stated here include the continued global impact of COVID-19 and related governmental and other actions taken in response, trend in growth with passenger power and connectivity on airplanes, the state of the aerospace and defense industries, the market acceptance of newly developed products, internal production capabilities, the timing of orders received, the status of customer certification processes and delivery schedules, the demand for and market acceptance of new or existing aircraft which contain the Company's products, the need for new and advanced test and simulation equipment, customer preferences and relationships, the effectiveness of the Company's supply chain, and other factors which are described in filings by Astronics with the Securities and Exchange Commission. The Company assumes no obligation to update forward-looking information in this news release whether to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial conditions or prospects, or otherwise.

    FINANCIAL TABLES FOLLOW

     

    ASTRONICS CORPORATION

    CONSOLIDATED STATEMENT OF OPERATIONS DATA

    (Unaudited, $ in thousands except per share data)

     

     

     

     

     

     

    Three Months Ended

     

    Six Months Ended

     

    7/1/2023

     

    7/2/2022

     

    7/1/2023

     

    7/2/2022

    Sales1

    $

    174,454

     

     

    $

    129,127

     

     

    $

    330,992

     

     

    $

    245,303

     

    Cost of products sold2

     

    141,759

     

     

     

    113,418

     

     

     

    270,787

     

     

     

    209,661

     

    Gross profit

     

    32,695

     

     

     

    15,709

     

     

     

    60,205

     

     

     

    35,642

     

    Gross margin

     

    18.7

    %

     

     

    12.2

    %

     

     

    18.2

    %

     

     

    14.5

    %

     

     

     

     

     

     

     

     

    Selling, general and administrative

     

    30,299

     

     

     

    24,105

     

     

     

    60,179

     

     

     

    48,205

     

    SG&A % of sales

     

    17.4

    %

     

     

    18.7

    %

     

     

    18.2

    %

     

     

    19.7

    %

    Income (loss) from operations

     

    2,396

     

     

     

    (8,396

    )

     

     

    26

     

     

     

    (12,563

    )

    Operating margin

     

    1.4

    %

     

     

    (6.5

    )%

     

     

    —

    %

     

     

    (5.1

    )%

     

     

     

     

     

     

     

     

    Net gain on sale of business3

     

    —

     

     

     

    —

     

     

     

    (3,427

    )

     

     

    (11,284

    )

    Other expense (income)4

     

    378

     

     

     

    291

     

     

     

    (910

    )

     

     

    753

     

    Interest expense, net

     

    5,920

     

     

     

    1,662

     

     

     

    11,390

     

     

     

    3,293

     

    Loss before tax

     

    (3,902

    )

     

     

    (10,349

    )

     

     

    (7,027

    )

     

     

    (5,325

    )

    Income tax expense

     

    8,097

     

     

     

    661

     

     

     

    9,387

     

     

     

    8,786

     

    Net loss

    $

    (11,999

    )

     

    $

    (11,010

    )

     

    $

    (16,414

    )

     

    $

    (14,111

    )

    Net loss % of sales

     

    (6.9

    )%

     

     

    (8.5

    )%

     

     

    (5.0

    )%

     

     

    (5.8

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    *Basic loss per share:

    $

    (0.37

    )

     

    $

    (0.34

    )

     

    $

    (0.50

    )

     

    $

    (0.44

    )

    *Diluted loss per share:

    $

    (0.37

    )

     

    $

    (0.34

    )

     

    $

    (0.50

    )

     

    $

    (0.44

    )

     

     

     

     

     

     

     

     

    *Weighted average diluted shares outstanding (in thousands)

     

    32,614

     

     

     

    32,082

     

     

     

    32,560

     

     

     

    32,007

     

     

     

     

     

     

     

     

     

    Capital expenditures

    $

    2,233

     

     

    $

    1,333

     

     

    $

    3,806

     

     

    $

    2,493

     

    Depreciation and amortization

    $

    6,711

     

     

    $

    7,000

     

     

    $

    13,373

     

     

    $

    14,088

     

    _______________________________
    1In the six months ended July 1, 2023, $5.8 million was recognized in sales related to the reversal of a deferred revenue liability recorded with a previous acquisition within our Test Systems Segment.
    2In the six months ended July 2, 2022, $6.0 million of the Aviation Manufacturing Jobs Protection Program grant was recognized as an offset to cost of products sold.
    3 Net gain on sale of business for the six months ended July 1, 2023 and July 2, 2022 is comprised of the additional gain on the sale of the Company's former semiconductor test business resulting from the contingent earnout for the 2022 and 2021 calendar year, respectively.
    4 Other expense (income) for the six months ended July 1, 2023 includes income of $1.8 million associated with the reversal of a liability related to an equity investment, as we will no longer be required to make the associated payment.

    ASTRONICS CORPORATION

    SEGMENT DATA

    (Unaudited, $ in thousands)

     

     

     

     

    Three Months Ended

     

    Six Months Ended

     

    7/1/2023

    7/2/2022

     

    7/1/2023

    7/2/2022

    Sales

     

     

     

     

     

    Aerospace

    $

    158,386

     

    $

    109,300

     

     

    $

    294,101

     

    $

    210,694

     

    Less inter-segment

     

    (4

    )

     

    (10

    )

     

     

    (122

    )

     

    (10

    )

    Total Aerospace

     

    158,382

     

     

    109,290

     

     

     

    293,979

     

     

    210,684

     

     

     

     

     

     

     

    Test Systems1

     

    16,072

     

     

    19,840

     

     

     

    37,013

     

     

    34,638

     

    Less inter-segment

     

    —

     

     

    (3

    )

     

     

    —

     

     

    (19

    )

    Total Test Systems

     

    16,072

     

     

    19,837

     

     

     

    37,013

     

     

    34,619

     

     

     

     

     

     

     

    Total consolidated sales

     

    174,454

     

     

    129,127

     

     

     

    330,992

     

     

    245,303

     

     

     

     

     

     

     

    Segment operating profit (loss) and margins

     

     

     

     

     

    Aerospace2

     

    13,719

     

     

    (3,276

    )

     

     

    17,806

     

     

    (226

    )

     

     

    8.7

    %

     

    (3.0

    )%

     

     

    6.1

    %

     

    (0.1

    )%

    Test Systems1

     

    (6,143

    )

     

    (26

    )

     

     

    (6,740

    )

     

    (1,813

    )

     

     

    (38.2

    )%

     

    (0.1

    )%

     

     

    (18.2

    )%

     

    (5.2

    )%

    Total segment operating profit (loss)

     

    7,576

     

     

    (3,302

    )

     

     

    11,066

     

     

    (2,039

    )

     

     

     

     

     

     

     

     

     

     

     

     

    Net gain on sale of business

     

    —

     

     

    —

     

     

     

    (3,427

    )

     

    (11,284

    )

    Interest expense

     

    5,920

     

     

    1,662

     

     

     

    11,390

     

     

    3,293

     

    Corporate expenses and other3

     

    5,558

     

     

    5,385

     

     

     

    10,130

     

     

    11,277

     

    Loss before taxes

    $

    (3,902

    )

    $

    (10,349

    )

     

    $

    (7,027

    )

    $

    (5,325

    )

    ________________________________
    1 In the six months ended July 1, 2023, $5.8 million was recognized in sales related to the reversal of a deferred revenue liability recorded with a previous acquisition within our Test Systems Segment, which also benefits operating loss for the period. Absent that benefit, Test Systems operating loss was $12.6 million.
    2 In the six months ended July 2, 2022, $6.0 million of the Aviation Manufacturing Jobs Protection Program grant was recognized as an offset to the cost of products sold in the Aerospace segment.
    3 Corporate expenses and other for the six months ended July 1, 2023 includes income of $1.8 million associated with the reversal of a liability related to an equity investment, as we will no longer be required to make the associated payment.

    Reconciliation to Non-GAAP Performance Measures

    In addition to reporting net income, a U.S. generally accepted accounting principle ("GAAP") measure, we present Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, non-cash equity-based compensation expense, goodwill, intangible and long-lived asset impairment charges, equity investment income or loss, legal reserves, settlements and recoveries, restructuring charges, gains or losses associated with the sale of businesses and grant benefits recorded related to the AMJP program), which is a non-GAAP measure. The Company's management believes Adjusted EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the performance of its core operations from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, equity-based compensation expense, goodwill, intangible and long-lived asset impairment charges, equity investment income or loss, legal reserves, settlements and recoveries, litigation-related expenses, restructuring charges, gains or losses associated with the sale of businesses and grant benefits recorded related to the AMJP program, which is not commensurate with the core activities of the reporting period in which it is included. As such, the Company uses Adjusted EBITDA as a measure of performance when evaluating its business and as a basis for planning and forecasting. Adjusted EBITDA is not a measure of financial performance under GAAP and is not calculated through the application of GAAP. As such, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. Adjusted EBITDA, as presented, may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.

    ASTRONICS CORPORATION

    RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA

    (Unaudited, $ in thousands)

     

     

     

     

     

     

     

     

     

    Consolidated

     

    Three Months Ended

     

    Six Months Ended

     

    7/1/2023

     

    7/2/2022

     

    7/1/2023

     

    7/2/2022

    Net loss

    $

    (11,999

    )

     

    $

    (11,010

    )

     

    $

    (16,414

    )

     

    $

    (14,111

    )

    Add back (deduct):

     

     

     

     

     

     

     

    Interest expense

     

    5,920

     

     

     

    1,662

     

     

     

    11,390

     

     

     

    3,293

     

    Income tax expense

     

    8,097

     

     

     

    661

     

     

     

    9,387

     

     

     

    8,786

     

    Depreciation and amortization expense

     

    6,711

     

     

     

    7,000

     

     

     

    13,373

     

     

     

    14,088

     

    Equity-based compensation expense

     

    1,593

     

     

     

    1,620

     

     

     

    3,992

     

     

     

    3,721

     

    Restructuring-related charges including severance

     

    564

     

     

     

    90

     

     

     

    564

     

     

     

    174

     

    Legal reserve, settlements and recoveries

     

    (1,305

    )

     

     

    —

     

     

     

    (1,305

    )

     

     

    —

     

    Non-cash accrued 401K contribution

     

    1,328

     

     

     

    1,186

     

     

     

    2,536

     

     

     

    2,197

     

    Litigation-related legal expenses

     

    4,935

     

     

     

    872

     

     

     

    9,450

     

     

     

    2,174

     

    Equity investment accrued payable write-off

     

    —

     

     

     

    —

     

     

     

    (1,800

    )

     

     

    —

     

    AMJP grant benefit

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (6,008

    )

    Net gain on sale of business

     

    —

     

     

     

    —

     

     

     

    (3,427

    )

     

     

    (11,284

    )

    Deferred liability recovery

     

    —

     

     

     

    —

     

     

     

    (5,824

    )

     

     

    —

     

    Adjusted EBITDA

    $

    15,844

     

     

    $

    2,081

     

     

    $

    21,922

     

     

    $

    3,030

     

     

     

     

     

     

     

     

     

    Sales

    $

    174,454

     

     

    $

    129,127

     

     

    $

    330,992

     

     

    $

    245,303

     

    Adjusted EBITDA margin on sales

     

    9.1

    %

     

     

    1.6

    %

     

     

    6.6

    %

     

    1.2

    %

     

    ASTRONICS CORPORATION

    CONSOLIDATED BALANCE SHEET DATA

    ($ in thousands)

     

    (unaudited)

     

     

     

    7/1/2023

     

    12/31/2022

    ASSETS

     

     

     

    Cash and cash equivalents

    $

    3,472

     

    $

    13,778

    Restricted cash

     

    822

     

     

    —

    Accounts receivable and uncompleted contracts

     

    170,806

     

     

    147,790

    Inventories

     

    207,446

     

     

    187,983

    Other current assets

     

    15,650

     

     

    15,743

    Property, plant and equipment, net

     

    87,800

     

     

    90,658

    Other long-term assets

     

    37,274

     

     

    21,633

    Intangible assets, net

     

    72,108

     

     

    79,277

    Goodwill

     

    58,210

     

     

    58,169

    Total assets

    $

    653,588

     

    $

    615,031

     

     

     

     

    LIABILITIES AND SHAREHOLDERS' EQUITY

     

     

     

    Current maturities of long-term debt

    $

    8,960

     

    $

    4,500

    Accounts payable and accrued expenses

     

    137,920

     

     

    114,545

    Customer advances and deferred revenue

     

    27,288

     

     

    32,567

    Long-term debt

     

    168,733

     

     

    159,500

    Other liabilities

     

    80,286

     

     

    63,999

    Shareholders' equity

     

    230,401

     

     

    239,920

    Total liabilities and shareholders' equity

    $

    653,588

     

    $

    615,031

     

    ASTRONICS CORPORATION

    CONSOLIDATED CASH FLOWS DATA

     

     

     

     

     

    Six Months Ended

    (Unaudited, $ in thousands)

    7/1/2023

     

    7/2/2022

    Cash flows from operating activities:

     

     

     

    Net loss

    $

    (16,414

    )

     

    $

    (14,111

    )

    Adjustments to reconcile net loss to cash from operating activities:

     

     

     

    Non-cash items:

     

     

     

    Depreciation and amortization

     

    13,373

     

     

     

    14,088

     

    Amortization of deferred financing fees

     

    1,363

     

     

     

    —

     

    Provisions for non-cash losses on inventory and receivables

     

    1,705

     

     

     

    677

     

    Equity-based compensation expense

     

    3,992

     

     

     

    3,721

     

    Net gain on sale of business

     

    (3,427

    )

     

     

    (11,284

    )

    Operating lease non-cash expense

     

    2,563

     

     

     

    2,928

     

    Non-cash 401K contribution accrual

     

    2,536

     

     

     

    2,197

     

    Non-cash deferred liability reversal

     

    (5,824

    )

     

     

    —

     

    Other

     

    (1,275

    )

     

     

    1,320

     

    Cash flows from changes in operating assets and liabilities:

     

     

     

    Accounts receivable

     

    (22,619

    )

     

     

    (11,449

    )

    Inventories

     

    (22,638

    )

     

     

    (19,293

    )

    Prepaid expenses and other current assets

     

    472

     

     

     

    (3,030

    )

    Accounts payable

     

    14,081

     

     

     

    11,660

     

    Accrued expenses

     

    5,460

     

     

     

    (458

    )

    Income taxes payable/receivable

     

    7,422

     

     

     

    16,909

     

    Operating lease liabilities

     

    (2,674

    )

     

     

    (3,601

    )

    Customer advance payments and deferred revenue

     

    959

     

     

     

    (389

    )

    Supplemental retirement plan and other liabilities

     

    (206

    )

     

     

    (215

    )

    Net cash from operating activities

     

    (21,151

    )

     

     

    (10,330

    )

    Cash flows from investing activities:

     

     

     

    Proceeds on sale of business and assets

     

    3,427

     

     

     

    21,977

     

    Capital expenditures

     

    (3,806

    )

     

     

    (2,493

    )

    Net cash from investing activities

     

    (379

    )

     

     

    19,484

     

    Cash flows from financing activities:

     

     

     

    Proceeds from long-term debt

     

    131,732

     

     

     

    52,625

     

    Principal payments on long-term debt

     

    (112,774

    )

     

     

    (79,625

    )

    Stock award and employee stock purchase plan activity

     

    (601

    )

     

     

    104

     

    Finance lease principal payments

     

    (24

    )

     

     

    (55

    )

    Financing-related costs

     

    (6,388

    )

     

     

    (771

    )

    Net cash from financing activities

     

    11,945

     

     

     

    (27,722

    )

    Effect of exchange rates on cash

     

    101

     

     

     

    (505

    )

    Decrease in cash and cash equivalents and restricted cash

     

    (9,484

    )

     

     

    (19,073

    )

    Cash and cash equivalents and restricted cash at beginning of period

     

    13,778

     

     

     

    29,757

     

    Cash and cash equivalents and restricted cash at end of period

    $

    4,294

     

     

    $

    10,684

     

    ASTRONICS CORPORATION

    SALES BY MARKET

    (Unaudited, $ in thousands)

     

     

     

     

     

     

    Three Months Ended

     

    Six Months Ended

    2023 YTD

     

    7/1/2023

    7/2/2022

    % Change

     

    7/1/2023

    7/2/2022

    % Change

    % of Sales

    Aerospace Segment

     

     

     

     

     

     

     

     

    Commercial Transport

    $

    112,079

    $

    69,243

    61.9

    %

     

    $

    206,292

    $

    133,332

    54.7

    %

    62.3

    %

    Military Aircraft

     

    13,584

     

    13,897

    (2.3

    )%

     

     

    27,648

     

    28,873

    (4.2

    )%

    8.4

    %

    General Aviation

     

    25,015

     

    18,130

    38.0

    %

     

     

    44,463

     

    33,997

    30.8

    %

    13.4

    %

    Other

     

    7,704

     

    8,020

    (3.9

    )%

     

     

    15,576

     

    14,482

    7.6

    %

    4.7

    %

    Aerospace Total

     

    158,382

     

    109,290

    44.9

    %

     

     

    293,979

     

    210,684

    39.5

    %

    88.8

    %

     

     

     

     

     

     

     

     

     

    Test Systems Segment1

     

     

     

     

     

     

     

     

    Government & Defense

     

    16,072

     

    19,837

    (19.0

    )%

     

     

    37,013

     

    34,619

    6.9

    %

    11.2

    %

     

     

     

     

     

     

     

     

     

    Total Sales

    $

    174,454

    $

    129,127

    35.1

    %

     

    $

    330,992

    $

    245,303

    34.9

    %

     

     

    SALES BY PRODUCT LINE

    (Unaudited, $ in thousands)

     

     

     

     

     

     

    Three Months Ended

     

    Six Months Ended

    2023 YTD

     

    7/1/2023

    7/2/2022

    % Change

     

    7/1/2023

    7/2/2022

    % Change

    % of Sales

    Aerospace Segment

     

     

     

     

     

     

     

     

    Electrical Power & Motion

    $

    67,946

    $

    42,135

    61.3

    %

     

    $

    121,400

    $

    86,602

    40.2

    %

    36.7

    %

    Lighting & Safety

     

    41,918

     

    31,388

    33.5

    %

     

     

    78,471

     

    60,599

    29.5

    %

    23.7

    %

    Avionics

     

    30,923

     

    24,406

    26.7

    %

     

     

    60,664

     

    43,281

    40.2

    %

    18.3

    %

    Systems Certification

     

    7,620

     

    1,669

    356.6

    %

     

     

    13,297

     

    2,671

    397.8

    %

    4.0

    %

    Structures

     

    2,271

     

    1,672

    35.8

    %

     

     

    4,571

     

    3,049

    49.9

    %

    1.4

    %

    Other

     

    7,704

     

    8,020

    (3.9

    )%

     

     

    15,576

     

    14,482

    7.6

    %

    4.7

    %

    Aerospace Total

     

    158,382

     

    109,290

    44.9

    %

     

     

    293,979

     

    210,684

    39.5

    %

    88.8

    %

     

     

     

     

     

     

     

     

     

    Test Systems Segment1

     

    16,072

     

    19,837

    (19.0

    )%

     

     

    37,013

     

    34,619

    6.9

    %

    11.2

    %

     

     

     

     

     

     

     

     

     

    Total Sales

    $

    174,454

    $

    129,127

    35.1

    %

     

    $

    330,992

    $

    245,303

    34.9

    %

     

    ________________________________
    1 Test Systems sales in the six months ended July 1, 2023 included a $5.8 million reversal of a deferred revenue liability recorded with a previous acquisition.

    ASTRONICS CORPORATION

    ORDER AND BACKLOG TREND

    (Unaudited, $ in thousands)

     

    Q3 2022

    Q4 2022

    Q1 2023

    Q2 2023

    Trailing

    Twelve Months

     

    10/1/2022

    12/31/2022

    4/1/2023

    7/1/2023

    7/1/2023

    Sales

     

     

     

     

     

    Aerospace

    $

    112,177

    $

    138,335

    $

    135,597

    $

    158,382

    $

    544,491

    Test Systems1

     

    19,261

     

    19,818

     

    20,941

     

    16,072

     

    76,092

    Total Sales1

    $

    131,438

    $

    158,153

    $

    156,538

    $

    174,454

    $

    620,583

     

     

     

     

     

     

    Bookings

     

     

     

     

     

    Aerospace

    $

    165,719

    $

    151,688

    $

    150,096

    $

    188,800

    $

    656,303

    Test Systems

     

    18,433

     

    30,707

     

    7,740

     

    18,252

     

    75,132

    Total Bookings

    $

    184,152

    $

    182,395

    $

    157,836

    $

    207,052

    $

    731,435

     

     

     

     

     

     

    Backlog

     

     

     

     

     

    Aerospace

    $

    464,307

    $

    477,660

    $

    492,159

    $

    522,577

     

    Test Systems

     

    82,807

     

    93,696

     

    86,319

     

    88,499

     

    Total Backlog

    $

    547,114

    $

    571,356

    $

    578,478

    $

    611,076

     

    N/A

     

     

     

     

     

     

    Book:Bill Ratio

     

     

     

     

     

    Aerospace

     

    1.48

     

    1.10

     

    1.11

     

    1.19

     

    1.21

    Test Systems1

     

    0.96

     

    1.55

     

    0.51

     

    1.14

     

    1.07

    Total Book:Bill1

     

    1.40

     

    1.15

     

    1.05

     

    1.19

     

    1.19

    ________________________________
    1 In the first quarter of 2023, Test Systems and Total sales includes the $5.8 million reversal of a deferred revenue liability. The book:bill ratios have been calculated excluding the impact of that transaction.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230803576443/en/

    Get the next $ATRO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATRO

    DatePrice TargetRatingAnalyst
    11/26/2025$65.00Buy
    TD Cowen
    10/10/2025$60.00Buy
    Craig Hallum
    7/11/2025$49.00Hold → Buy
    Truist
    9/20/2021$19.00Neutral → Buy
    Colliers Securities
    More analyst ratings

    $ATRO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on Astronics with a new price target

    TD Cowen initiated coverage of Astronics with a rating of Buy and set a new price target of $65.00

    11/26/25 8:35:28 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Craig Hallum initiated coverage on Astronics with a new price target

    Craig Hallum initiated coverage of Astronics with a rating of Buy and set a new price target of $60.00

    10/10/25 8:36:00 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics upgraded by Truist with a new price target

    Truist upgraded Astronics from Hold to Buy and set a new price target of $49.00

    7/11/25 7:55:26 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    $ATRO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Astronics Corporation Announces Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call and Webcast

    Astronics Corporation (NASDAQ:ATRO), a leading provider of advanced technologies for global aerospace, defense and other mission critical industries, announced that it will release its fourth quarter and fiscal year 2025 financial results after the close of financial markets on Tuesday, February 24, 2026. The Company will host a conference call and webcast that same day to review its financial and operating results and discuss its corporate strategies and outlook. A question-and-answer session will follow. Fourth Quarter and Fiscal Year 2025 Conference Call Tuesday, February 24, 2026 4:45 p.m. Eastern Time Phone: (201) 493-6784 Webcast: investors.astronics.com A telephonic replay wi

    2/10/26 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation Announces Preliminary Unaudited Adjusted EBITDA Margins for Fourth Quarter and Full Year 2025; Also Announces Plan to Webcast Presentation at the TD Cowen Aerospace & Defense Conference

    Refined preliminary unaudited fourth quarter and full year revenue estimates Fourth quarter adjusted EBITDA margin1 benefited from favorable mix Maintains initial 2026 revenue guidance of $950 million to $990 million, an increase of 10% to 15% over 2025 To webcast presentation at TD Cowen Aerospace & Defense Conference on February 12, 2026 Astronics Corporation (NASDAQ:ATRO), a leading provider of advanced technologies for global aerospace, defense and other mission critical industries, today reported preliminary, unaudited fourth quarter and full year 2025 financial results for the period ended December 31, 2025. Preliminary Fiscal 2025 Fourth Quarter Financial Results Up

    2/5/26 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Initiates Revenue Guidance for 2026

    Preliminary unaudited fourth quarter revenue of $236 million to $239 million Full-year 2025 preliminary unaudited revenue at mid-point of fourth quarter was approximately $860 million, an increase of 8% over 2024 Initial 2026 revenue guidance established at $950 million to $990 million, an increase of 10% to 15% over 2025 Astronics Corporation (NASDAQ:ATRO), a leading provider of advanced technologies for global aerospace, defense and other mission critical industries, announced its fourth quarter 2025 preliminary unaudited revenue was approximately $236 million to $239 million, above the Company's guidance range. At the midpoint, preliminary revenue was up approximately 14% over

    1/8/26 9:00:00 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    $ATRO
    SEC Filings

    View All

    Astronics Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ASTRONICS CORP (0000008063) (Filer)

    2/5/26 4:19:24 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation filed SEC Form 8-K: Regulation FD Disclosure, Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ASTRONICS CORP (0000008063) (Filer)

    1/14/26 5:08:36 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ASTRONICS CORP (0000008063) (Filer)

    1/8/26 9:03:50 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    $ATRO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive VP & Pres-Aerospace Peabody Mark gifted 500 units of $.01 PV Com Stk and gifted 2,000 units of $.01 PV CL B STK, increasing direct ownership by 236% to 183,445 units (SEC Form 4)

    4 - ASTRONICS CORP (0000008063) (Issuer)

    2/11/26 4:05:39 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Director Frisby Jeffry D gifted 500 units of $.01 PV Com Stk, decreasing direct ownership by 1% to 45,523 units (SEC Form 4)

    4 - ASTRONICS CORP (0000008063) (Issuer)

    12/10/25 4:12:07 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Director Frisby Jeffry D gifted 500 units of $.01 PV Com Stk, decreasing direct ownership by 1% to 46,023 units (SEC Form 4)

    4 - ASTRONICS CORP (0000008063) (Issuer)

    12/8/25 4:44:05 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    $ATRO
    Financials

    Live finance-specific insights

    View All

    Astronics Corporation Announces Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call and Webcast

    Astronics Corporation (NASDAQ:ATRO), a leading provider of advanced technologies for global aerospace, defense and other mission critical industries, announced that it will release its fourth quarter and fiscal year 2025 financial results after the close of financial markets on Tuesday, February 24, 2026. The Company will host a conference call and webcast that same day to review its financial and operating results and discuss its corporate strategies and outlook. A question-and-answer session will follow. Fourth Quarter and Fiscal Year 2025 Conference Call Tuesday, February 24, 2026 4:45 p.m. Eastern Time Phone: (201) 493-6784 Webcast: investors.astronics.com A telephonic replay wi

    2/10/26 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation Reports 2025 Third Quarter Financial Results

    Third quarter sales increased 3.8% to $211.4 million driven by Aerospace growth of 8.5% to $192.7 million Third quarter net loss was $11.1 million, reflecting $32.6 million in refinancing-related charges; adjusted EBITDA1 was $32.7 million, or 15.5% of sales Aerospace operating margin was 16.2% and adjusted operating margin1 was 16.7% Solid quarterly bookings of $210.4 million and backlog of $646.7 million Generated $34.2 million in cash from operations Refinancing activities included the issuance of a convertible bond during the third quarter and the initiation of a cash flow revolver subsequent to quarter end Expect fourth quarter revenue to be $225 to $235 million, resulting

    11/4/25 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation Announces Third Quarter 2025 Financial Results Conference Call and Webcast

    Astronics Corporation (NASDAQ:ATRO), a leading supplier of advanced technologies and products to the global aerospace, defense, and other mission critical industries, announced that it will release its third quarter 2025 financial results after the close of financial markets on Tuesday, November 4, 2025. The Company will host a conference call and webcast that same day to review its financial and operating results and discuss its corporate strategies and outlook. A question-and-answer session will follow. Third Quarter 2025 Conference Call Tuesday, November 4, 2025 4:45 p.m. Eastern Time Phone: (201) 493-6784 Webcast: investors.astronics.com A telephonic replay will be available fro

    10/21/25 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    $ATRO
    Leadership Updates

    Live Leadership Updates

    View All

    Astronics Corporation Appoints Fay West to its Board of Directors

    Astronics Corporation (NASDAQ:ATRO), a leading provider of advanced technologies for global aerospace, defense and other mission critical industries, announced the appointment of Fay West to its Board of Directors, effective February 6, 2025. Ms. West brings over two decades of financial leadership experience across various industries. Since April 2021, she has served as Senior Vice President and Chief Financial Officer at Tennant Company (NYSE:TNC), a global leader in designing, manufacturing, and marketing solutions that help create a cleaner, safer, and healthier world. Peter J. Gundermann, Chairman, President and CEO, commented, "We are thrilled to welcome Fay to our Board of Director

    2/7/25 8:00:00 AM ET
    $ATRO
    $KWR
    $TNC
    Military/Government/Technical
    Industrials
    Major Chemicals
    Industrial Machinery/Components

    Astronics Corporation Appoints Nancy L. Hedges as Chief Financial Officer Effective January 4, 2025

    To succeed David C. Burney upon his retirement Astronics Corporation (NASDAQ:ATRO) ("Astronics" or the "Company") today announced that its Board of Directors has appointed Nancy L. Hedges, currently Controller and Principal Accounting Officer, to Vice President and Chief Financial Officer effective upon the retirement of David C. Burney, the Company's current CFO, on January 3, 2025. Peter J. Gundermann, Chairman, President and Chief Executive officer, commented, "Nancy has attained strong command of our financial landscape across the broad range of our business, and has been intimately involved in our financial strategies and recent financing activities. She has an excellent working know

    10/15/24 8:30:00 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation Appoints Linda O'Brien to Its Board of Directors

    Astronics Corporation (NASDAQ:ATRO), a leading supplier of advanced technologies and products to the global aerospace and defense industries, today announced the appointment of Linda O'Brien to its Board of Directors, effective February 24, 2023. Ms. O'Brien is Vice President and Chief Engineer at Lockheed Martin Aeronautics, a position she has held since 2021. She was originally employed by Lockheed/General Dynamics from 1986 to 2006, rejoining the company in 2016. She has held a variety of positions including Program Management Director and Deputy Vice President of ISR and Unmanned Systems, Engineering Director- Deputy to the Vice President of Engineering and Technology and Engineering Di

    3/2/23 6:30:00 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    $ATRO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Astronics Corporation

    SC 13G - ASTRONICS CORP (0000008063) (Subject)

    12/12/24 5:27:21 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13G/A filed by Astronics Corporation

    SC 13G/A - ASTRONICS CORP (0000008063) (Subject)

    11/14/24 11:42:53 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    SEC Form SC 13G/A filed by Astronics Corporation (Amendment)

    SC 13G/A - ASTRONICS CORP (0000008063) (Subject)

    2/13/24 4:58:57 PM ET
    $ATRO
    Military/Government/Technical
    Industrials